Letter: Is Body-Mass Index Really Associated With Fibrosis Regression During Long-Term Nucleoside Analogue Therapy in Chronic Hepatitis B? Authors’ Reply
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.13899
Full Text
Open PDFAbstract
Available in full text
Date
January 2, 2017
Authors
Publisher
Wiley